Hydroxyurea treatment of meningiomas: A pilot study

Skull Base

Volumn 16, Issue 3, 2006, Pages 157-160

  Weston, Gabriel J ^a   Martin, Andrew J ^a   Mufti, Ghulam J ^b   Strong, Anthony J ^b   Gleeson, Michael J ^c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Hydroxyurea; Meningioma

Indexed keywords

HYDROXYUREA;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; GINGIVITIS; HEMATOLOGICAL PARAMETERS; HUMAN; MALIGNANT MENINGIOMA; NAUSEA AND VOMITING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; SKIN BRUISING; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; URINARY TRACT INFECTION; VOLUMETRY;

EID: 33748506905     PISSN: 15315010     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-949518     Document Type: Article

References (16)

1. Chamberlain MC. Meningiomas. Curr Treat Options Neurol 2001;3:67-76
2. Gonzales MF. Classification of brain tumours. In: Kaye AH, Laws ER. Brain Tumours. Edinburgh: Churchill Livingstone; 1995:675
3. De Monte F. Current management of meningiomas. Oncology (Williston Park) 1995;9:83-91, 96; discussion 96, 99-100
4. Akeyson EW, McCutcheon IE. Management of benign and aggressive intracranial meningiomas. Oncology (Williston Park) 1996;10:747-756; discussion 756-759
5. Mason WP, Gentili F, Macdonald DR, Hariharan S, Cruz CR, Abrey LE. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg 2002;97:341-346
6. Marks SM, Whitwell HL, Lye RH. Recurrence of meningiomas after operation. Surg Neurol 1986;25:436-440
7. Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994;80:195-201
8. Kondziolka D, Levy EI, Niranjan A, Flickinger JC, Lunsford LD. Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg 1999;91:44-50
9. Grunberg SM, Weiss MH. Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma. J Neurooncol 1990;8:61-65
10. Kaba SE, De Monte F, Bruner JM, et al. The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery 1997;40:271-275
11. Kyritsis AP. Chemotherapy for meningiomas. J Neurooncol 1996;29:269-272
12. Schrell UM, Rittig MG, Anders M, et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 1997;86:845-852
13. Schrell UM, Rittig MG, Anders M, et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 1997;86:840-844
14. Newton HB, Slivka MA, Stevens C. Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neurooncol 2000;49:165-170
15. Rosenthal MA, Ashley DL, Cher L. Treatment of high risk or recurrent meningiomas with hydroxyurea. J Clin Neurosci 2002;9:156-158
16. Paus S, Klockgether T, Urbach H, Schlegel U. Meningioma of the optic nerve sheath: treatment with hydroxyurea. J Neurol Neurosurg Psychiatry 2003;74:1348-1350